Clinical Trial Detail


Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at :

NCT ID NCT04205552
Title Neoadjuvant Nivolumab Combination Treatment in Resectable Non-small Cell Lung Cancer Patients (NEOpredict)
Recruitment Recruiting
Gender both
Phase Phase II
Variant Requirements No
Sponsors University Hospital, Essen

lung non-small cell carcinoma


Nivolumab + Relatlimab


Age Groups: adult | senior
Covered Countries DEU | BEL

Facility Status City State Zip Country Details
Jessa Hospital Hasselt Recruiting Hasselt Belgium Details
University Hospital Essen Recruiting Essen Germany Details
Netherlands Cancer Institute Not yet recruiting Amsterdam Netherlands Details
*Shaded cells indicate that there was no data available from for the field